Development and Application of Organic Sonosensitizers in Cancer Therapy

Abstract

Sonodynamic therapy (SDT) is an innovative cancer therapy modality that harnesses the energy of ultrasound to activate sonosensitizers for producing reactive oxygen species (ROS), culminating in the eradication of tumor cells. Compared with photodynamic therapy, SDT has the capacity to penetrate deeply into biological tissues, thereby holding significant promise for addressing deeply situated or surgically inaccessible tumors. The effectiveness of SDT is greatly dependent on the characteristics of the sonosensitizers, and unlike inorganic sonosensitizers, organic sonosensitizers offer a more controlled synthesis process and have excellent biocompatibility. This review presents a meticulous undertaking to categorize organic sonosensitizers and elucidate their mechanisms of action and therapeutic effects in the context of SDT. Design strategies for sonosensitizers are also summarized, and we emphasize the critical role of nanotechnology in tumor localization, imaging, and multimodal synergistic therapy, offering an innovative approach for achieving precise tumor targeting. In addition, the synergistic impact of SDT is delineated when integrated with other oncological modalities, such as photothermal therapy and photodynamic therapy, to enhance therapeutic efficacy. Finally, the review also discusses challenges and future perspectives for the advancement of clinical SDT within the realm of oncology.

Keywords

combination therapy / nanotechnology / organic sonosensitizers / sonodynamic therapy / tumor therapy

References

[1] Z. Gong and Z. Dai, “Design and challenges of sonodynamic therapy system for cancer theranostics: from equipment to sensitizers,” Advanced Science 8, no. 10 (2021): 2002178.

[2] L. Zhou, C. Dong, L. Ding, et al., “Targeting ferroptosis synergistically sensitizes apoptotic sonodynamic anti-tumor nanotherapy,” Nano Today 39 (2021): 101212.

[3] S. Liang, X. Deng, P. Ma, Z. Cheng, and J. Lin, “Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy,” Advanced Materials 32, no. 47 (2020): e2003214.

[4] Q. L. Guo, X. L. Dai, M. Y. Yin, et al., “Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives,” Military Medical Research 9, no. 1 (2022): 26.

[5] D. Huang, J. Wang, C. Song, and Y. Zhao, “Ultrasound-responsive matters for biomedical applications,” Innovation (Camb) 4, no. 3 (2023): 100421.

[6] M. Zhan, F. Wang, Y. Liu, et al., “Dual-Cascade Activatable Nanopotentiators Reshaping Adenosine Metabolism for Sono-Chemodynamic-Immunotherapy of Deep Tumors,” Advance Science 10, no. 10 (2023): e2207200.

[7] W. Li, M. Liang, J. Qi, and D. Ding, “Semiconducting Polymers for Cancer Immunotherapy,” Macromolecular Rapid Communications 44, no. 23 (2023): e2300496.

[8] D. Huang, J. Wang, X. Fu, Y. Zhao, and L. Sun, “Bio-Inspired Temporospatial Catalytic Cascades Systems Based on Ultrasound-Triggered Multicomponent Piezoelectric Microparticles,” Aggregate 5, no. 4 (2024): e534.

[9] Y. Shen, Y. Chen, Y. Huang, et al., “An in vitro study on the antitumor effect of sonodynamic therapy using sinoporphyrin sodium on human glioblastoma cells,” Ultrasonics 110 (2021): 106272.

[10] Y. W. An, H. Q. Liu, Z. Q. Zhou, et al., “Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma,” Oncology Reports 44, no. 4 (2020): 1596.

[11] Y. Sun, H. Wang, K. Zhang, et al., “Sonodynamic therapy induces oxidative stress, DNA damage and apoptosis in glioma cells,” RSC Advances 8, no. 63 (2018): 36245.

[12] X. Wang, X. Zhong, L. Bai, et al., “Ultrafine Titanium Monoxide (TiO_1+x) Nanorods for Enhanced Sonodynamic Therapy,” Journal of the American Chemical Society 142, no. 14 (2020): 6527.

[13] X. Lin, S. Liu, X. Zhang, et al., “An Ultrasound Activated Vesicle of Janus Au-MnO Nanoparticles for Promoted Tumor Penetration and Sono-Chemodynamic Therapy of Orthotopic Liver Cancer,” Angewandte Chemie International Edition 59, no. 4 (2020): 1682.

[14] C. Dai, S. Zhang, Z. Liu, R. Wu, and Y. Chen, “Two-Dimensional Graphene Augments Nanosonosensitized Sonocatalytic Tumor Eradication,” ACS Nano 11, no. 9 (2017): 9467.

[15] Y. Dong, S. Dong, B. Liu, et al., “2D Piezoelectric Bi2MoO6 Nanoribbons for GSH-Enhanced Sonodynamic Therapy,” Advanced Materials 33, no. 51 (2021): e2106838.

[16] X. Xing, S. Zhao, T. Xu, et al., “Advances and Perspectives in Organic Sonosensitizers for Sonodynamic Therapy,” Coordination Chemistry Reviews 445, no. Oct. (2021): 214087. 1.

[17] K. Liu, Z. Jiang, F. Zhao, et al., “Triarylboron-Doped Acenethiophenes as Organic Sonosensitizers for Highly Efficient Sonodynamic Therapy With Low Phototoxicity,” Advanced Materials 34, no. 49 (2022): e2206594.

[18] T. Hu, T. Wang, Y. Yang, et al., “2D MOFs Nanosheets Derived From 2D LDHs as a Multifunctional Sensitizer for Sono-photodynamic Therapy-mediated Tumor Treatment,” Chemical Engineering Journal 505 (2025): 159771.

[19] Y. Wang, Y. Zhou, J. Wang, et al., “Nucleolin-targeted Silicon-based Nanoparticles for Enhanced Chemo-sonodynamic Therapy of Diffuse Large B-cell Lymphoma,” International Journal of Pharmaceutics 671 (2025): 125294.

[20] M. Pourhajibagher and S. Etemad-Moghadam, “Modulation of the Triggered Apoptosis by Nano Emodin Transfersome-mediated Sonodynamic Therapy on Head and Neck Squamous Cell Carcinoma Cell Lines,” Photodiagnosis and Photodynamic Therapy 34 (2021): 102253.

[21] Y. Shen, J. Ou, X. Chen, et al., “An in Vitro Study on Sonodynamic Treatment of human Colon Cancer Cells Using Sinoporphyrin Sodium as Sonosensitizer,” Biomedical Engineering Online 19 (2020): 52.

[22] G. Varchi, F. Foglietta, R. Canaparo, et al., “Engineered Porphyrin Loaded Core-Shell Nanoparticles for Selective Sonodynamic Anticancer Treatment,” Nanomedicine (Lond) 10, no. 23 (2015): 3483.

[23] K. Ninomiya, A. Fukuda, C. Ogino, and N. Shimizu, “Targeted Sonocatalytic Cancer Cell Injury Using Avidin-conjugated Titanium Dioxide Nanoparticles,” Ultrasonics Sonochemistry 21, no. 5 (2014): 1624.

[24] I. Toubia, C. Nguyen, S. Diring, et al., “Development of Targeted Photodynamic Therapy Drugs by Combining a Zinc Phthalocyanine Sensitizer With TSPO or EGFR Binding Groups: The Impact of the Number of Targeting Agents on Biological Activity,” Organic & Biomolecular Chemistry 21, no. 32 (2023): 6509.

[25] X. Zhu, S. Zhang, Y. Cao, et al., “Black phosphorus nanosheets-based tumor microenvironment responsive multifunctional nanosystem for highly efficient photo-/sono-synergistic therapy of non-Hodgkin lymphoma,” Chinese Chemical Letters 34, no. 10 (2023): 223.

[26] C. Deng, J. Zhang, F. Hu, et al., “A GSH-Responsive Prodrug With Simultaneous Triple-Activation Capacity for Photodynamic/Sonodynamic Combination Therapy With Inhibited Skin Phototoxicity,” Small 20, no. 40 (2024): 2400667.

[27] Y. Liu, H. Wang, M. Ding, et al., “Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models,” Nano Letters 24, no. 28 (2024): 8741-8751.

[28] Y. Zhang, A. R. Khan, X. Yang, Y. Shi, X. Zhao, and G. Zhai, “A Sonosensitiser-Based Polymeric Nanoplatform for Chemo-Sonodynamic Combination Therapy of Lung Cancer,” Journal of Nanobiotechnology 19, no. 1 (2021): 57.

[29] R. J. Browning, S. Able, J. L. Ruan, et al., “Combining Sonodynamic Therapy With Chemoradiation for the Treatment of Pancreatic Cancer,” Journal of Controlled Release 337 (2021): 371.

[30] S. Son, J. H. Kim, X. Wang, et al., “Multifunctional Sonosensitizers in Sonodynamic Cancer Therapy,” Journal of Controlled Release 49, no. 11 (2020): 3244.

[31] H. Yang, R. Liu, Y. Xu, L. Qian, and Z. Dai, “Photosensitizer nanoparticles boost photodynamic therapy for pancreatic cancer treatment,” Nano-Micro Letters 13, no. 1 (2021): 35.

[32] X. Lin, R. Huang, Y. Huang, et al., “Nanosonosensitizer-Augmented Sonodynamic Therapy Combined With Checkpoint Blockade for Cancer Immunotherapy,” International Journal of Nanomedicine 16 (2021): 1889.

[33] C. Deng, M. Zheng, S. Han, et al., “GSH-Activated Porphyrin Sonosensitizer Prodrug for Fluorescence Imaging-Guided Cancer Sonodynamic Therapy,” Advanced Functional Materials 33, no. 32 (2023): 2300348.

[34] W. Droge, “Free Radicals in the Physiological Control of Cell Function,” Physiological Reviews 82, no. 1 (2002): 47.

[35] Y. Wang, P. Su, Z. Lin, et al., “A Tribo/Piezoelectric Nanogenerator Based on Bio-MOFs for Energy Harvesting and Antibacterial Wearable Device,” Advanced Materials 37 (2025): 2418207.

[36] H. Chen, M. Wang, Q. Yang, et al., “Multifunctional Porphyrinic Metal-organic Framework-based Nanoplatform Regulating Reactive Oxygen Species Achieves Efficient Imaging-guided Cascaded Nanocatalytic Therapy,” Journal of Colloid & Interface Science 684 (2025): 423-438.

[37] M. Wu, Z. Zhang, D. Li, et al., “Integrating Oxygen-boosted Sonodynamic Therapy and Ferroptosis via Engineered Exosomes for Effective Cancer Treatment,” Theranostics 15, no. 1 (2025): 68.

[38] L. Zhang, X. Xie, J. Tao, et al., “Mystery of Bisphenol F-induced Nonalcoholic Fatty Liver Disease-Like Changes: Roles of Drp1-mediated Abnormal Mitochondrial Fission in Lipid Droplet Deposition,” Science of the Total Environment 904 (2023): 166831.

[39] Z. Zhang, W. Zeng, N. Guo, et al., “A Nanodrug Loading Indocyanine Green and Metformin Dually Alleviating Tumor Hypoxia for Enhanced Chemodynamic/Sonodynamic Therapy,” Journal of Colloid & Interface Science 680 (2025): 341-355.

[40] M. Li, Q. Liu, S. Xie, et al., “Transformable Tumor Microenvironment-Responsive Oxygen Vacancy-Rich MnO₂ @Hydroxyapatite Nanospheres for Highly Efficient Cancer Sonodynamic Immunotherapy,” Advanced Science (2025): 2414162.

[41] W. Li, Z. Lin, J. Liu, et al., “Pt(IV) Prodrug as a Potent Nanosonosensitizer Self-cyclically Amplifies Sonodynamic-chemotherapy With Dually Reversing Cisplatin Resistance,” Journal of Materials Chemistry B 13 (2025): 3186-3197.

[42] Y. Zheng, G. R. Williams, R. Hu, et al., “Acid-Unlocked Two-Layer Ca-Loaded Nanoplatform to Interfere with Mitochondria for Synergistic Tumor Therapy,” International Journal of Nanomedicine 20 (2025): 1899-1920.

[43] M. Waldeck-Weiermair, S. Yadav, F. Spyropoulos, et al., “Dissecting in vivo and in vitro redox responses using chemogenetics,” Computers in Biology and Medicine 177 (2021): 360-369.

[44] G. Ma, K. Cheng, X. Wang, et al., “Dual Oxygen Supply System of Carbon Dot-loaded Microbubbles With Acoustic Cavitation for Enhanced Sonodynamic Therapy in Diabetic Wound Healing,” Biomaterials 318 (2025): 123145.

[45] H. Wang, L. Hang, H. Qu, et al., “Renal-Clearable Metalloporphyrin Complex-Based Nanosonosensitizers Using Photoacoustic Imaging Guiding to Enhance Sonodynamic Cancer Therapy,” ACS Applied Materials & Interfaces 17 (2025): 10509-10523.

[46] M. Y. Araujo, P. T. Zeferino, and V. L. R. Fonseca, “Sonodynamic Therapy: Ultrasound Parameters and in Vitro Experimental Configurations,” International Journal of Pharmaceutics 610 (2021): 121243.

[47] V. Choi, M. A. Rajora, and G. Zheng, “Activating Drugs With Sound: Mechanisms behind Sonodynamic Therapy and the Role of Nanomedicine,” Bioconjugate Chemistry 31, no. 4 (2020): 967.

[48] J. Tang, C. Guha, and W. A. Tome, “Biological Effects Induced by Non-thermal Ultrasound and Implications for Cancer Therapy,” Technology in Cancer Research & Treatment 14, no. 2 (2015): 221.

[49] D. Huang, M. Nie, J. Wang, Y. Zhao, and L. Sun, “Spatiotemporal Piezoelectric Microcapsules for Programmable Sonodynamic Sterilization and Wound Healing,” Chemical Engineering Journal 499 (2024): 156183.

[50] K. Logan, F. Foglietta, H. Nesbitt, et al., “Targeted Chemo-sonodynamic Therapy Treatment of Breast Tumours Using Ultrasound Responsive Microbubbles Loaded With paclitaxel, Doxorubicin and Rose Bengal,” European Journal of Pharmaceutics and Biopharmaceutics 139 (2019): 224.

[51] Y. He, S. H. Liu, J. Yin, and J. Yoon, “Sonodynamic and Chemodynamic Therapy Based on Organic/Organometallic Sensitizers,” Coordination Chemistry Reviews 429 (2021): 213610.

[52] D. Huang, Y. Cheng, G. Chen, and Y. Zhao, “3D-Printed Janus Piezoelectric Patches for Sonodynamic Bacteria Elimination and Wound Healing,” Research 6 (2023): 0022.

[53] Y. He, T. Wang, Y. Song, et al., “Targeting Vascular Destruction by Sonosensitizer-Free Sonocatalytic Nanomissiles Instigates Thrombus Aggregation and Nutrition Deprivation to Starve Pancreatic Cancer,” Advanced Functional Materials 34, no. 30 (2024): 2315394.

[54] X. Pan, Z. Huang, J. Guo, et al., “MOF-Derived Nanoparticles With Enhanced Acoustical Performance for Efficient Mechano-Sonodynamic Therapy,” Advanced Materials 36, no. 33 (2024): 2400142.

[55] Y. Yang, C. Ji, Z. H. Zhu, et al., “Metal-Organic Frameworks Based on Fluorogens With Aggregation-Induced Emission for Enhanced Sonodynamic Therapy,” Chemistry of Materials 36, no. 10 (2024): 4955-4966.

[56] C. Li, F. Teng, F. Wu, H. Zhang, C. Zhang, and D. Zhang, “Enhanced Cavitation Dose and Reactive Oxygen Species Production in Microbubble-mediated Sonodynamic Therapy for Inhibition of Escherichia coli and Biofilm,” Ultrasonics Sonochemistry 105 (2024): 106853.

[57] K. Moroi and T. Sato, “Comparison Between Procaine and Isocarboxazid Metabolism in Vitro by a Liver Microsomal Amidase-esterase,” Biochemical Pharmacology 24, no. 16 (1975): 1517.

[58] Z. Gao, J. Zheng, B. Yang, et al., “Sonodynamic Therapy Inhibits Angiogenesis and Tumor Growth in a Xenograft Mouse Model,” Cancer Letters 335, no. 1 (2013): 93.

[59] Y. Zhao, M. Wen, N. Yu, et al., “Design and Synthesis of Cancer-cell-membrane-camouflaged Hemoporfin-Cu₉Se₈ Nanoagents for Homotypic Tumor-targeted Photothermal-sonodynamic Therapy,” Journal of Colloid & Interface Science 637 (2023): 225.

[60] S. M. Z. Uddin, D. E. Komatsu, T. Motyka, and S. Petterson, “Low-Intensity Continuous Ultrasound Therapies—A Systematic Review of Current State-of-the-Art and Future Perspectives,” Journal of Clinical Medicine 10, no. 12 (2021): 2698.

[61] C. Li, Y. Lu, L. Cheng, X. Zhang, J. Yue, and J. Liu, “Combining Mechanical High-Intensity Focused Ultrasound Ablation With Chemotherapy for Augmentation of Anticancer Immune Responses,” Molecular Pharmaceutics 18, no. 5 (2021): 2091.

[62] M. Du, Y. Li, Q. Zhang, J. Zhang, S. Ouyang, and Z. Chen, “The Impact of Low Intensity Ultrasound on Cells: Underlying Mechanisms and Current Status,” Progress in Biophysics and Molecular Biology 174 (2022): 41.

[63] J. Chen, H. Luo, Y. Liu, et al., “Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer,” ACS Nano 11, no. 12 (2017): 12849.

[64] M. Yuan, S. Liang, Y. Zhou, et al., “A Robust Oxygen-Carrying Hemoglobin-Based Natural Sonosensitizer for Sonodynamic Cancer Therapy,” Nano Letters 21, no. 14 (2021): 6042.

[65] J. Ouyang, Z. Tang, N. Farokhzad, et al., “Ultrasound Mediated Therapy: Recent Progress and Challenges in Nanoscience,” Nano Today 35 (2020): 100949.

[66] W. Sun, C. Chu, S. Li, et al., “Nanosensitizer-mediated Unique Dynamic Therapy Tactics for Effective Inhibition of Deep Tumors,” Advanced Drug Delivery Reviews 192 (2023): 114643.

[67] X. Liu, J. Wang, Y. Wu, M. Wu, and J. Song, “Ultrasound Activated Probe for Disease Imaging and Therapy in-Vivo,” Advanced Drug Delivery Reviews 205 (2024): 115158.

[68] J. Chen, Q. Zhou, and W. Cao, “Multifunctional Porphyrin-Based Sonosensitizers for Sonodynamic Therapy,” Advanced Functional Materials 34 (2024): 2405844.

[69] L. Hang, M. Li, Y. Zhang, et al., “Mn(Ⅱ) Optimized Sono/Chemodynamic Effect of Porphyrin-Metal-Organic Framework Nanosheets for MRI-Guided Colon Cancer Therapy and Metastasis Suppression,” Small 20, no. 15 (2024): 2306364.

[70] P. Xu, C. Wen, C. Gao, et al., “Near-Infrared-Ⅱ-Activatable Self-Assembled Manganese Porphyrin-Gold Heterostructures for Photoacoustic Imaging-Guided Sonodynamic-Augmented Photothermal/Photodynamic Therapy,” ACS Nano 18, no. 1 (2023): 713.

[71] P. Geng, Y. Li, D. K. Macharia, et al., “One Stone, Three Birds: Design and Synthesis of “All-in-One” Nanoscale Mn-Porphyrin Coordination Polymers for Magnetic Resonance Imaging-Guided Synergistic Photodynamic-Sonodynamic Therapy,” Journal of Colloid and Interface Science 660 (2024): 1021.

[72] M. Das, V. Pandey, K. Jajoria, D. Bhatia, I. Gupta, and H. Shekhar, “Glycosylated Porphyrin Derivatives for Sonodynamic Therapy: ROS Generation and Cytotoxicity Studies in Breast Cancer Cells.,” ACS Omega 99, no. 1 (2023): 1196.

[73] Y. Kuang, Z. Zhang, K. Zhu, et al., “Porphyrin-based-MOF Nanocomposite Hydrogels for Synergistic Sonodynamic and Gas Therapy Against Tumor,” International Journal of Biological Macromolecules 280 (2024): 136086.

[74] T. Jia, J. R. Du, J. N. Yang, et al., “Metalloporphyrin MOFs-Based Nanoagent Enabling Tumor Microenvironment Responsive Sonodynamic Therapy of Intracranial Glioma Signaled by NIR-IIb Luminescence Imaging,” Advanced Functional Materials 34, no. 3 (2024): 2307816.

[75] G. G. Köse and A. Erdoğmuş, “Dual Effect of Light and Ultrasound for Efficient Singlet Oxygen Generation With Novel Diaxial Silicon Phthalocyanine Sensitizer,” Photochemistry and Photobiology 100, no. 1 (2024): 52.

[76] N. Zhang, W. Zeng, Y. Xu, et al., “Pyroptosis Induction With Nanosonosensitizer-Augmented Sonodynamic Therapy Combined With PD-L1 Blockade Boosts Efficacy Against Liver Cancer,” Advanced Healthcare Materials 13, no. 7 (2024): 2302606.

[77] Q. Bai, M. Wang, K. Wang, J. Liu, F. Qu, and H. Lin, “CuPc-Fe@BSA Nanocomposite: Intracellular Acid-sensitive Aggregation for Enhanced Sonodynamic and Chemo-therapy,” Journal of Colloid and Interface Science 671 (2024): 577.

[78] L. C. Nene and H. Abrahamse, “Design Consideration of Phthalocyanines as Sensitizers for Enhanced Sono-photodynamic Combinatorial Therapy of Cancer,” Acta Pharmaceutica Sinica B 14 (2023): 1077.

[79] D. Li, S. Cai, P. Wang, et al., “Innovative Design Strategies Advance Biomedical Applications of Phthalocyanines,” Advanced Healthcare Materials 12, no. 22 (2023): 2300263.

[80] X. Kong, Y. Yang, X. Ren, Y. Lin, Y. Shi, and Z. Liu, “External Stimuli-triggered Photodynamic and Sonodynamic Therapies in Combination With Hybrid Nanomicelles of ICG@PEP@HA: Laser vs. ultrasound,” Nanoscale 16, no. 15 (2024): 7547.

[81] Y. Chen, B. Wu, H. Shang, et al., “Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma,” International Journal of Nanomedicine 18 (2023): 6059.

[82] H. Tian, H. Shang, Y. Chen, et al., “Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis against Hepatocellular Carcinoma,” International Journal of Nanomedicine 18 (2023): 7079.

[83] Y. Rao, T. Fan, L. Zhou, et al., “A Positive Self-amplified H₂O₂ and Acidity Circulation for Boosting CDT-PTT-starvation Therapy,” Journal of Controlled Release 354 (2023): 701.

[84] H. Huang, L. Du, R. Su, et al., “Albumin-based co-loaded Sonosensitizer and STING Agonist Nanodelivery System for Enhanced Sonodynamic and Immune Combination Antitumor Therapy,” Journal of Controlled Release 375 (2024): 524.

[85] D. Kuron, A. Pohlmann, L. Angenendt, et al., “Amsacrine-based Induction Therapy in AML Patients With Cardiac Comorbidities: A Retrospective Single-center Analysis,” Annal of Hematology 102, no. 4 (2023): 755.

[86] H. M. Liu, X. P. Xiong, J. W. Wu, et al., “Discovery of Acridine-based LSD1 Inhibitors as Immune Activators Targeting LSD1 in Gastric Cancer,” European Journal of Medicinal Chemistry 251 (2023): 115255.

[87] S. Bhattacharya, B. G. Prajapati, S. Singh, and M. M. Anjum, “Nanoparticles Drug Delivery for 5-aminolevulinic Acid (5-ALA) in Photodynamic Therapy (PDT) for Multiple Cancer Treatment: A Critical Review on Biosynthesis, Detection, and Therapeutic Applications,” Journal of Cancer Research and Clinical Oncology 149, no. 19 (2023): 17607.

[88] F. Galieva, M. Khalifa, Z. Akhmetzyanova, et al., “New Supramolecular Hypoxia-Sensitive Complexes Based on Azo-Thiacalixarene,” Molecules 28, no. 2 (2023): 466.

[89] M. Li, Z. Liu, J. Tang, et al., “Facile Synthesis of a Multifunctional Porous Organic Polymer Nanosonosensitizer (mHM@HMME) for Enhanced Cancer Sonodynamic Therapy,” ACS Applied Materials & Interfaces 16 (2024): 28104.

[90] F. Zhuang, Q. Ma, C. Dong, et al., “Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy,” ACS Nano 16, no. 4 (2022): 5439.

[91] Z. Jiang, W. Xiao, and Q. Fu, “Stimuli Responsive Nanosonosensitizers for Sonodynamic Therapy,” Journal of Controlled Release 361 (2023): 547.

[92] X. Meng, Z. Sun, H. Chu, and Y. Wang, “Self-assembled Nanoplatforms for Chemodynamic Therapy,” Chemical Engineering Journal 479 (2023): 147702.

[93] Z. Xiang, L. Xu, Y. Shan, et al., “Tumor microenvironment-responsive self-assembly of barium titanate nanoparticles with enhanced piezoelectric catalysis capabilities for efficient tumor therapy,” Bioactive Materials 33 (2024): 251.

[94] Z. Wang, B. Liu, Q. Sun, et al., “Upconverted Metal-Organic Framework Janus Architecture for Near-Infrared and Ultrasound Co-Enhanced High Performance Tumor Therapy,” ACS Nano 15, no. 7 (2021): 12342.

[95] Y. Jin, Q. Zhou, J. Geng, et al., “Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined with Pulsed Low-Intensity Ultrasound on PC-9 Cells,” Frontiers in Pharmacology 12 (2021): 792360.

[96] Q. Duan, H. Li, J. Xue, et al., “Effective Combination of Targeted Therapies With Sonodynamic Treatment for Use in Exploring Differences in Therapeutic Efficacy Across Organelle Targets,” Molecular Pharmaceutics 21, no. 2 (2024): 760.

[97] Z. Wang, Q. Sun, B. Liu, et al., “Recent Advances in Porphyrin-based MOFs for Cancer Therapy and Diagnosis Therapy,” Coordination Chemistry Reviews 439 (2021): 213945.

[98] H. Tsuru, H. Shibaguchi, M. Kuroki, Y. Yamashita, and M. Kuroki, “Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer,” Free Radical Biology and Medicine 53, no. 3 (2012): 464.

[99] T. Jia, J. Du, J. Yang, et al., “Metalloporphyrin MOFs-Based Nanoagent Enabling Tumor Microenvironment Responsive Sonodynamic Therapy of Intracranial Glioma Signaled by NIR-IIb Luminescence Imaging,” Advanced Functional Materials 34, no. 3 (2024): 2307816.

[100] L. Sun, J. Zhang, M. Xu, et al., “Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer,” ACS Applied Materials & Interfaces 14, no. 1 (2022): 452.

[101] J. N. Le, S. J. Madsen, O. A. Gederaas, K. Berg, A. Høgset, and H. Hirschberg, “Induction Chemotherapy Docetaxel, Cisplatin, 5-Fluorouracil Followed by Concurrent Chemoradiotherapy in Stage IVA Nasopharyngeal Carcinoma,” Clinical Oncology and Research 3, no. 5 (2020): 1.

[102] P. H. Zhao, Y. L. Wu, X. Y. Li, et al., “Aggregation-Enhanced Sonodynamic Activity of Phthalocyanine-Artesunate Conjugates,” Angewandte Chemie International Edition 61, no. 5 (2022): e202113506.

[103] Y. Gong, X. Wang, F. Gong, et al., “Phthalocyanine iron nanodots for combined chemodynamic-sonodynamic cancer therapy,” Science China Materials 65, no. 9 (2022): 2600-2608.

[104] C. Li, Y. Gao, Y. Wang, et al., “Bifunctional Nano-Assembly of Iridium(III) Phthalocyanine Complex Encapsulated With BSA: Hypoxia-Relieving/Sonosensitizing Effects and Their Immunogenic Sonodynamic Therapy,” Advanced Functional Materials 33, no. 5 (2023): 2210348.

[105] C. C. Karanlık, F. Aguilar-Galindo, L. Sobotta, E. Guzel, and A. Erdogmus, “Combination of Light and Ultrasound: Exploring Sono-Photochemical Activities of Phthalocyanine-Based Sensitizers,” The Journal of Physical Chemistry C 127, no. 19 (2023): 9145.

[106] Y. Liu, S. Chen, J. Sun, et al., “Folate-Targeted and Oxygen/Indocyanine Green-Loaded Lipid Nanoparticles for Dual-Mode Imaging and Photo-sonodynamic/Photothermal Therapy of Ovarian Cancer in Vitro and in Vivo,” Molecular Pharmaceutics 16, no. 10 (2019): 4104.

[107] B. Wang, S. Hu, Y. Teng, et al., “Current Advance of Nanotechnology in Diagnosis and Treatment for Malignant Tumors,” Signal Transduction and Targeted Therapy 9, no. 1 (2024): 200.

[108] P. Liu, S. Lan, D. Gao, et al., “Targeted Blood-brain Barrier Penetration and Precise Imaging of Infiltrative Glioblastoma Margins Using Hybrid Cell Membrane-coated ICG Liposomes,” Journal of Nanobiotechnology 22, no. 1 (2024): 603.

[109] T. Wu, Y. Liu, Y. Cao, and Z. Liu, “Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of Glioblastoma,” Advanced Materials 34, no. 15 (2022): 2110364.

[110] N. Nomikou, C. Sterrett, C. Arthur, B. McCaughan, J. F. Callan, and A. P. McHale, “The Effects of Ultrasound and Light on Indocyanine-Green-Treated Tumour Cells and Tissues,” Chemmedchem 7, no. 8 (2012): 1465.

[111] M. Zheng, P. Zhao, Z. Luo, et al., “Robust ICG Theranostic Nanoparticles for Folate Targeted Cancer Imaging and Highly Effective Photothermal Therapy,” ACS Applied Materials & Interfaces 6, no. 9 (2014): 6709.

[112] H. Tian, H. Shang, Y. Chen, et al., “Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis against Hepatocellular Carcinoma,” International Journal of Nanomedicine 18 (2023): 7079.

[113] D. Li, Y. Yang, D. Li, J. Pan, C. Chu, and G. Liu, “Organic Sonosensitizers for Sonodynamic Therapy: From Small Molecules and Nanoparticles Toward Clinical Development,” Small 17, no. 42 (2021): e2101976.

[114] N. Suzuki, K. Okada, S. Chida, C. Komori, Y. Shimada, and T. Suzuki, “Antitumor effect of acridine orange under ultrasonic irradiation in vitro,” Anticancer Research 27 (2007): 4179-4184.

[115] J. Gao, Y. Guo, J. Wang, et al., “Spectroscopic Investigation on the Sonodynamic Activity of Amsacrine (AMSA) to Bovine Serum Albumin (BSA) Damage,” Journal of Luminescence: An Interdisciplinary Journal of Research on Excited State Processes in Condensed Matter 131, no. 10 (2011): 2046.

[116] J. C. Kennedy and R. H. Pottier, “New Trends in Photobiology,” Journal of Photochemistry and Photobiology B: Biology 14, no. 4 (1992): 275.

[117] S. Wang, Z. Hu, X. Wang, et al., “5-Aminolevulinic Acid-mediated Sonodynamic Therapy Reverses Macrophage and Dendritic Cell Passivity in Murine Melanoma Xenografts,” Ultrasound in Medicine & Biology 40, no. 9 (2014): 2125.

[118] Z. Hu, H. Fan, G. Lv, et al., “5-Aminolevulinic Acid-mediated Sonodynamic Therapy Induces Anti-tumor Effects in Malignant Melanoma via p53-miR-34a-Sirt1 Axis,” Journal of Dermatological Science 79, no. 2 (2015): 155.

[119] Z. Xiao, B. Zhuang, G. Zhang, M. Li, and Y. Jin, “Pulmonary Delivery of Cationic Liposomal Hydroxycamptothecin and 5-aminolevulinic Acid for Chemo-sonodynamic Therapy of Metastatic Lung Cancer,” International Journal of Pharmaceutics 601 (2021): 120572.

[120] W. Yang, H. Xu, Q. Liu, et al., “5-Aminolevulinic Acid Hydrochloride Loaded Microbubbles-mediated Sonodynamic Therapy in Pancreatic Cancer Cells,” Artificial Cells, Nanomedicine, and Biotechnology 48, no. 1 (2020): 1178.

[121] I. Rosenthal, J. Z. Sostaric, and P. Riesz, “Sonodynamic Therapy—a Review of the Synergistic Effects of Drugs and Ultrasound,” Ultrasonics Sonochemistry 11, no. 6 (2004): 349.

[122] R. Hou, X. Liang, X. Li, X. Zhang, X. Ma, and F. Wang, “In Situ Conversion of Rose Bengal Microbubbles Into Nanoparticles for Ultrasound Imaging Guided Sonodynamic Therapy With Enhanced Antitumor Efficacy,” Biomaterials Science 8, no. 9 (2020): 2526.

[123] Z. Mao, H. Rha, J. Kim, et al., “THQ-Xanthene: An Emerging Strategy to Create Next-Generation NIR-I/II Fluorophores,” Advanced Science 10, no. 18 (2023): 2301177.

[124] Y. Yang, J. Huang, M. Liu, et al., “Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy,” Advanced Science 10, no. 2 (2023): e2204365.

[125] J. Chen, J. Zhang, X. Wei, et al., “Chemodynamic Therapy Agent Optimized Mesoporous TiO₂ Nanoparticles for Glutathione-Enhanced and Hypoxia-Tolerant Synergistic Chemo-Sonodynamic Therapy,” Journal of Colloid and Interface Science 650 (2023): 1773.

[126] X. Zheng, W. Liu, J. Ge, et al., “Biodegradable Natural Product-Based Nanoparticles for Near-Infrared Fluorescence Imaging-Guided Sonodynamic Therapy,” ACS Applied Materials & Interfaces 11, no. 20 (2019): 18178.

[127] G. Y. Lesher, E. J. Froelich, M. D. Gruett, J. H. Bailey, and R. P. Brundage, “1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents,” Journal of Medicinal and Pharmaceutical Chemistry 5 (1962): 1063.

[128] M. Wang, X. Wang, B. Liu, et al., “Synthesis of Ciprofloxacin-capped Gold Nanoparticles Conjugates With Enhanced Sonodynamic Antimicrobial Activity in Vitro,” Journal of Pharmaceutical Sciences 112, no. 1 (2023): 336.

[129] A. Chrzanowska, P. Roszkowski, A. Bielenica, W. Olejarz, K. Stepien, and M. Struga, “Anticancer and Antimicrobial Effects of Novel Ciprofloxacin Fatty Acids Conjugates,” European Journal of Medicinal Chemistry 185 (2020): 111810.

[130] V. Yadav and P. Talwar, “Repositioning of Fluoroquinolones From Antibiotic to Anti-cancer Agents: An Underestimated Truth,” Biomedicine & Pharmacotherapy 111 (2019): 934.

[131] W. Li, Y. Song, X. Liang, et al., “Mutual-reinforcing Sonodynamic Therapy Against Rheumatoid Arthritis Based on Sparfloxacin Sonosensitizer Doped Concave-cubic Rhodium Nanozyme,” Biomaterials 276 (2021): 121063.

[132] W. Dai, H. Dong, and X. Zhang, “Two-Dimensional Biodegradable L -Cysteine-Iodine Nanosheets for Computed Tomography-Guided Cancer Synergistic Sonodynamic Therapy and Chemotherapy,” ACS Applied Materials & Interfaces 16, no. 42 (2024): 56696-56704.

[133] Q. Dai, L. Xie, E. Ren, and G. Liu, “Cathepsin B Responsive Peptide-Purpurin Conjugates Assembly-Initiated in Situ Self-Aggregation for Cancer Sonotheranostics,” Nano Letters 24, no. 3 (2024): 950-957.

[134] X. Shi, Y. Zhang, S. Xu, et al., “Unimolecule-based Size-charge Switchable Nanomedicine for Deep Cancer Sono-immunotherapy,” Nano Today 43 (2022): 101417.

[135] H. Wang, D. Li, H. Wang, et al., “Enhanced Sonodynamic Therapy for Deep Tumors Using a Self-Assembled Organoplatinum(Ⅱ) Sonosensitizer,” Journal of Medicinal Chemistry 67, no. 20 (2024): 18356-18367.

[136] N. Behzadpour, A. Ranjbar, N. Azarpira, and N. Sattarahmady, “Development of a Composite of Polypyrrole-Coated Carbon Nanotubes as a Sonosensitizer for Treatment of Melanoma Cancer under Multi-Step Ultrasound Irradiation,” Ultrasound in Medicine & Biology 46, no. 9 (2020): 2322.

[137] R. Teranishi, T. Matsuda, E. Yuba, K. Kono, and A. Harada, “Sonodynamic Therapeutic Effects of Sonosensitizers With Different Intracellular Distribution Delivered by Hollow Nanocapsules Exhibiting Cytosol Specific Release,” Macromolecular Bioscience 19, no. 4 (2019): e1800365.

[138] D. Y. Hou, Q. You, P. Zhang, et al., “Cascade-Activatable Nanoprodrug System Augments Sonochemotherapy of Bladder Cancer,” ACS Nano 18, no. 52 (2024): 35507-35519.

[139] F. Wang, Z. Wu, Y. Zhang, et al., “Semiconducting Polymer Nanoprodrugs Enable Tumor-specific Therapy via Sono-activatable Ferroptosis,” Biomaterials 312 (2025): 122722.

[140] J. Liu, S. Fu, J. Xie, et al., “Application of Self-Assembly Nanoparticles Based on DVDMS for Fenton-Like Ion Delivery and Enhanced Sonodynamic Therapy,” Biosensors 12, no. 4 (2022): 255.

[141] L. Ren, Q. Zhang, W. Wang, et al., “Co-assembly of Polymeric Conjugates Sensitizes Neoadjuvant Chemotherapy of Triple-negative Breast Cancer With Reduced Systemic Toxicity,” Acta Biomaterialia 175 (2024): 329.

[142] Y. Zheng, Z. Li, Y. Yang, H. Shi, H. Chen, and Y. Gao, “A Nanosensitizer Self-assembled From Oleanolic Acid and Chlorin e6 for Synergistic Chemo/Sono-photodynamic Cancer Therapy,” Phytomedicine 93 (2021): 153788.

[143] J. Zhao, E. Bian, R. Zhang, et al., “Self-Assembled Aza-Boron-Dipyrromethene-Based H₂S Prodrug for Synergistic Ferroptosis-Enabled Gas and Sonodynamic Tumor Therapies,” Advance Science 11, no. 30 (2024): 2309542.

[144] S. Ma, C. Liu, B. Li, T. Zhang, L. Jiang, and R. Wang, “Sonophoresis Enhanced Transdermal Delivery of Cisplatin in the Xenografted Tumor Model of Cervical Cancer,” OncoTargets and Therapy 13 (2020): 889.

[145] Z. Liu, S. Liu, B. Liu, et al., “Tumor Microenvironment-Activatable Metal-Phenolic Nanoformulations for Ultrasound-Boosted Ferroptosis Through Triple Regulatory Pathways,” Advanced Functional Materials 34, no. 44 (2024): 2407153.

[146] S. B. Wang, Z. X. Chen, F. Gao, et al., “Remodeling Extracellular Matrix Based on Functional Covalent Organic Framework to Enhance Tumor Photodynamic Therapy,” Biomaterials 234 (2020): 119772.

[147] Z. Song, X. Deng, L. Jiang, et al., “Copper-Consuming Nanoplatform for Alleviating Hypoxia and Overcoming Resistance to Sonodynamic Therapy of Breast Cancer,” ACS Applied Materials & Interfaces 16, no. 43 (2024): 58357-58369.

[148] D. Wang, Z. Zhang, L. Lin, et al., “Porphyrin-based Covalent Organic Framework Nanoparticles for Photoacoustic Imaging-guided Photodynamic and Photothermal Combination Cancer Therapy,” Biomaterials 223 (2019): 119459.

[149] K. Wang, Z. Zh ang, L. Lin, et al., “Cyanine-Assisted Exfoliation of Covalent Organic Frameworks in Nanocomposites for Highly Efficient Chemo-Photothermal Tumor Therapy,” ACS Applied Materials & Interfaces 11, no. 43 (2019): 39503.

[150] Y. Zhang, L. Zhang, Z. Wang, et al., “Renal-clearable Ultrasmall Covalent Organic Framework Nanodots as Photodynamic Agents for Effective Cancer Therapy,” Biomaterials 223 (2019): 119462.

[151] B. R. Xie, Y. Yu, X. H. Liu, et al., “A near Infrared Ratiometric Platform Based π-extended Porphyrin Metal-organic Framework for O₂ Imaging and Cancer Therapy,” Biomaterials 272 (2021): 120782.

[152] X. Li, Q. Zeng, and R. Zhang, “Mitochondria-specific Gadolinium (III) Porphyrinate as Efficient ROS Generator for MRI Visualization and Sonodynamic-immunotherapy of Deep Localized Tumors,” Chemical Engineering Journal 450 (2022): 138210.

[153] M. Li, Z. Liu, J. Tang, et al., “Facile Synthesis of a Multifunctional Porous Organic Polymer Nanosonosensitizer (mHM@HMME) for Enhanced Cancer Sonodynamic Therapy,” ACS Applied Materials & Interfaces 16, no. 22 (2024): 28104-28117.

[154] A. R. Sarkar and N. R. Jana, “Molecular Sonosensitizer-Loaded Polymer Nanomicelle for Ultrasound-Based Cell Therapy via Singlet Oxygen Generation,” ACS Applied Nano Materials 6, no. 22 (2023): 21282.

[155] P. Geng, Y. Li, D. K. Macharia, et al., “One Stone, Three Birds: Design and Synthesis of “All-in-One” Nanoscale Mn-Porphyrin Coordination Polymers for Magnetic Resonance Imaging-Guided Synergistic Photodynamic-Sonodynamic Therapy,” Journal of Colloid & Interface Science 660 (2024): 1021-1029.

[156] H. Peng, D. Wang, S. Huang, and A. Yu, “Dual-targeting Aggregation-induced emission polymer micelles mediate immunogenic sonodynamic therapy for Tumor cell growth inhibition and macrophage reprogramming,” Acta Biomaterialia 195 (2025): 321.

[157] M. Xu, Y. Hu, J. Wu, J. Liu, and K. Pu, “Sonodynamic Nano-LYTACs Reverse Tumor Immunosuppressive Microenvironment for Cancer Immunotherapy,” Journal of the American Chemical Society 146, no. 50 (2024): 34669-34680.

[158] P. Xu, C. Wen, C. Gao, et al., “Near-Infrared-II-Activatable Self-Assembled Manganese Porphyrin-Gold Heterostructures for Photoacoustic Imaging-Guided Sonodynamic-Augmented Photothermal/Photodynamic Therapy,” ACS Nano 18, no. 1 (2024): 713.

[159] Y. Zhang, Y. Ou, J. Guo, and X. Huang, “Retracted: Ultrasound-Triggered Breast Tumor Sonodynamic Therapy Through Hematoporphyrin Monomethyl Ether-Loaded Liposome,” Journal of Biomedical Materials Research Part B, Applied Biomaterials 108, no. 3 (2020): 948.

[160] C. T. G. Nguyen, J. H. Kang, J. Y. You, et al., “Safe and Targeted Sonodynamic Cancer Therapy Using Biocompatible Exosome-Based Nanosonosensitizers,” ACS Applied Materials & Interfaces 13, no. 22 (2021): 25575.

[161] M. Baneshi, S. Dadfarnia, A. M. H. Shabani, S. K. Sabbagh, S. Haghgoo, and H. Bardania, “A Novel Theranostic System of AS1411 Aptamer-functionalized Albumin Nanoparticles Loaded on Iron Oxide and Gold Nanoparticles for Doxorubicin Delivery,” International Journal of Pharmaceutics 564 (2019): 145.

[162] M. Sivasubramanian, Y. Wang, L. W. Lo, and L. D. Liao, “Personalized Cancer Therapeutics Using Photoacoustic Imaging-Guided Sonodynamic Therapy,” Ieee Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 70, no. 12 (2023): 1682.

[163] F. Tian, F. Li, L. Ren, et al., “Acoustic-Based Theranostic Probes Activated by Tumor Microenvironment for Accurate Tumor Diagnosis and Assisted Tumor Therapy,” ACS Sensors 7, no. 12 (2022): 3611.

[164] G. Wen, X. Li, Y. Zhang, et al., “Effective Phototheranostics of Brain Tumor Assisted by Near-Infrared-II Light-Responsive Semiconducting Polymer Nanoparticles,” ACS Applied Materials & Interfaces 12, no. 30 (2020): 33492.

[165] J. Zheng, Y. Sun, T. Long, et al., “Sonosensitizer Nanoplatform-mediated Sonodynamic Therapy Induced Immunogenic Cell Death and Tumor Immune Microenvironment Variation,” Drug Delivery 29, no. 1 (2022): 1164.

[166] S. Liu, Z. Liu, Q. Meng, C. Chen, and M. Pang, “Facile Synthesis of a Cubic Porphyrin-Based Covalent Organic Framework for Combined Breast Cancer Therapy,” ACS Applied Materials & Interfaces 13, no. 48 (2021): 56873.

[167] R. Canaparo, F. Foglietta, N. Barbero, and L. Serpe, “The Promising Interplay Between Sonodynamic Therapy and Nanomedicine,” Advanced Drug Delivery Reviews 189 (2022): 114495.

[168] J. Linares, M. Varese, A. Sallent-Aragay, et al., “Peptide-Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells,” Journal of Medicinal Chemistry 66, no. 5 (2023): 3348.

[169] F. Bosca, F. Foglietta, A. Gimenez, et al., “Exploiting Lipid and Polymer Nanocarriers to Improve the Anticancer Sonodynamic Activity of Chlorophyll,” Pharmaceutics 12, no. 7 (2020): 605.

[170] S. Jafari, M. Jadidi, H. Hasanzadeh, T. Khani, R. Nasr, and V. Semnani, “Sonodynamic Therapy of Mice Breast Adenocarcinoma With HP-MSN,” Iranian Journal of Science and Technology: IJST, Transaction A Science 44, no. 3 (2020): 651.

[171] Y. Zheng, J. Ye, Z. Li, H. Chen, and Y. Gao, “Recent Progress in Sono-photodynamic Cancer Therapy: From Developed New Sensitizers to Nanotechnology-based Efficacy-enhancing Strategies,” Acta Pharmaceutica Sinica B 11, no. 8 (2021): 2197.

[172] C. T. G. Nguyen, H. Q. Truong, E. J. Hong, et al., “Mitochondria-targeting sonosensitizer-loaded extracellular vesicles for chemo-sonodynamic therapy,” Journal of Controlled Release 354 (2023): 651-663.

[173] J. Zhou, J. Hou, S. Liu, et al., “Theranostic Nanoplatform With Sequential SDT and ADV Effects in Response to Well-Programmed LIFU Irradiation for Cervical Cancer,” International Journal of Nanomedicine 16 (2021): 7995.

[174] R. K. Samani, F. Maghsoudinia, and S. H. Masoumi, “Sonodynamic Therapy of the Breast Cancer Cells (4T1) Using Gold Nanoclusters-loaded Ultrasound-activated Nanodroplets,” Journal of Drug Delivery Science and Technology 90 (2023): 105125.

[175] X. Guan, H. H. Yin, X. H. Xu, et al., “Tumor Metabolism-Engineered Composite Nanoplatforms Potentiate Sonodynamic Therapy via Reshaping Tumor Microenvironment and Facilitating Electron-Hole Pairs' Separation,” Advanced Functional Materials 30, no. 27 (2020): 2000326.

[176] Z. Cao, D. Li, J. Wang, and X. Yang, “Reactive Oxygen Species-sensitive Polymeric Nanocarriers for Synergistic Cancer Therapy,” Acta Biomaterialia 130 (2021): 17.

[177] W. P. Li, C. H. Su, Y. C. Chang, Y. J. Lin, and C. S. Yeh, “Ultrasound-Induced Reactive Oxygen Species Mediated Therapy and Imaging Using a Fenton Reaction Activable Polymersome,” ACS Nano 10, no. 2 (2016): 2017.

[178] H. Liu, X. Chen, Y. Jia, et al., “Facing inevitable parpis resistance: mechanisms and therapeutic strategies for breast cancer treatment,” IMed 1, no. 2 (2023): e20220013.

[179] S. Lakkadwala, S. R. B. Dos, C. Sun, and J. Singh, “Biodistribution of TAT or QLPVM Coupled to Receptor Targeted Liposomes for Delivery of Anticancer Therapeutics to Brain in Vitro and in Vivo,” Nanomedicine 23 (2020): 102112.

[180] E. C. Smyth, M. Nilsson, H. I. Grabsch, N. C. van Grieken, and F. Lordick, “Gastric cancer,” Lancet 396, no. 10251 (2020): 635.

[181] K. Eto, N. Hiki, K. Kumagai, et al., “Prophylactic Effect of Neoadjuvant Chemotherapy in Gastric Cancer Patients With Postoperative Complications,” Gastric Cancer 21, no. 4 (2018): 703.

[182] M. Xu, L. Zhou, L. Zheng, et al., “Sonodynamic Therapy-derived Multimodal Synergistic Cancer Therapy,” Cancer Letters 497 (2021): 229.

[183] S. He, J. Yu, M. Xu, et al., “A Semiconducting Iron-Chelating Nano-Immunomodulator for Specific and Sensitized Sono-Metallo-Immunotherapy of Cancer,” Angewandte Chemie International Edition 62, no. 43 (2023): e202310178.

[184] P. E. Saw, Q. Liu, P. P. Wong, and E. Song, “Cancer Stem Cell Mimicry for Immune Evasion and Therapeutic Resistance,” Cell Stem Cell 31, no. 8 (2024): 1101-1112.

[185] G. R. Khosravi, S. Mostafavi, S. Bastan, N. Ebrahimi, R. S. Gharibvand, and N. Eskandari, “Immunologic Tumor Microenvironment Modulators for Turning Cold Tumors Hot,” Cancer Communications 44, no. 5 (2024): 521-553.

[186] N. Tao, H. Li, L. Deng, et al., “A Cascade Nanozyme With Amplified Sonodynamic Therapeutic Effects Through Comodulation of Hypoxia and Immunosuppression Against Cancer,” ACS Nano 16, no. 1 (2022): 485.

[187] Y. Li, J. Xie, W. Um, et al., “Sono/Photodynamic Nanomedicine-Elicited Cancer Immunotherapy,” Advanced Functional Materials 31 (2020): 2008061.

[188] M. Chen, Y. Sun, and H. Liu, “Cell Membrane Biomimetic Nanomedicines for Cancer Phototherapy,” Interdisciplinary Medicine 1 (2023): e20220012.

[189] D. Wang, M. Zhang, Y. Zhang, et al., “Intraparticle Double-Scattering-Decoded Sonogenetics for Augmenting Immune Checkpoint Blockade and CAR-T Therapy,” Advanced Science 9, no. 32 (2022): 2203106.

[190] H. Zhao, H. Zhao, Y. Jiao, et al., “Biosynthetic Molecular Imaging Probe for Tumor-targeted Dual-modal Fluorescence/Magnetic Resonance Imaging,” Biomaterials 256 (2020): 120220.

[191] W. Q. Huang, Y. Q. Zhu, W. You, et al., “Tumor Microenvironment Triggered the in Situ Synthesis of an Excellent Sonosensitizer in Tumor for Sonodynamic Therapy,” ACS Applied Materials & Interfaces 14, no. 23 (2022): 26469-26479.

[192] A. P. McHale and N. Nomikou, “Nanotechnology-based Platforms for Effective and Versatile Sonodynamic Therapy in Cancer Treatment,” Nanomedicine 19, no. 27 (2024): 2251-2255.

[193] Z. C. Jia, X. Yang, Y. K. Wu, et al., “The Art of Finding the Right Drug Target: Emerging Methods and Strategies,” Pharmacological Reviews 76, no. 5 (2024): 896-914.

[194] S. J. Park, S. Ju, W. J. Jung, et al., “Robust Genome Editing Activity and the Applications of Enhanced Miniature CRISPR-Cas12f1,” Nature Communications 16, no. 1 (2025): 677.

[195] H. Liu, S. Wang, J. Wang, et al., “Energy Metabolism in Health and Diseases,” Signal Transduction and Targeted Therapy 10, no. 1 (2025): 69.

[196] H. Ikeda, K. Kawase, T. Nishi, et al., “Immune evasion through mitochondrial transfer in the tumour microenvironment,” Nature (2025): 1-12.

[197] A. Shen, M. Arbesman, R. Lodha, et al., “Germline Pathogenic Variant-Positive Patients with Melanoma Exhibit Improved Response to Checkpoint Inhibitor Immunotherapy,” Journal of Investigative Dermatology (2025): S0022-202X.

[198] J. Huang, Z. Wang, F. Li, et al., “Ginseng polysaccharides circumvent acquired resistance to anti-PD-1 immunotherapy in patients with non-small cell lung cancer,” Pharmacological Research (2025): 107611.

[199] Y. Yao, C. Chen, B. Li, and W. Gao, “Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy,” Cancer Immunology, Immunotherapy 74, no. 3 (2025): 1-20.

[200] J. Yan, D. Wei, Z. Zhao, K. Sun, and Y. Sun, “Osteosarcoma-targeting PtIV prodrug amphiphile for enhanced chemo-immunotherapy via Ca²⁺ trapping,” Acta Biomaterialia 193 (2025): 474-483.

[201] Y. He, J. Wan, Y. Yang, et al., “Multifunctional Polypyrrole-Coated Mesoporous TiO(₂) Nanocomposites for Photothermal, Sonodynamic, and Chemotherapeutic Treatments and Dual-Modal Ultrasound/Photoacoustic Imaging of Tumors,” Advanced Healthcare Materials 8, no. 9 (2019): e1801254.

[202] X. Wang, X. Xu, Z. Yang, X. Xu, S. Han, and H. Zhang, “Improvement of the effectiveness of sonodynamic therapy: by optimizing components and combination with other treatments,” Biomaterials Science 11, no. 23 (2023): 7489.

[203] Z. Zhou, J. Huang, Z. Zhang, et al., “Bimetallic PdPt-based nanocatalysts for Photothermal-Augmented tumor starvation and sonodynamic therapy in NIR-II biowindow assisted by an oxygen Self-Supply strategy,” Chemical Engineering Journal 435 (2022): 135085.

[204] P. Wang, J. Chen, R. Zhong, et al., ”Recent advances of ultrasound-responsive nanosystems in tumor immunotherapy,“ European Journal of Pharmaceutics and Biopharmaceutics 198 (2024): 114246.

[205] Y. Wang, J. Zhan, J. Huang, et al., “Dynamic responsiveness of self-assembling peptide-based nano-drug systems,” Interdisciplinary Medicine 1, no. 1 (2023): e20220005.

[206] Z. Chen, W. Liu, Z. Yang, et al., ”Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy,“ Theranostics 13, no. 5 (2023): 1571.

[207] H. Lei, J. H. Kim, S. Son, et al., ”Immunosonodynamic therapy designed with activatable sonosensitizer and immune stimulant imiquimod,“ ACS Nano 16, no. 7 (2022): 10979.

[208] T. Yin, H. Chen, A. Ma, et al., “Cleavable collagenase-assistant nanosonosensitizer for tumor penetration and sonodynamic therapy,” Biomaterials 293 (2023): 121992.

[209] B. Geng, S. Xu, L. Shen, F. Fang, W. Shi, and D. Pan, “Multifunctional carbon dot/MXene heterojunctions for alleviation of tumor hypoxia and enhanced sonodynamic therapy,” Carbon 179 (2021): 493-504.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.